NASDAQ · MISCELLANEOUS CHEMICAL PRODUCTS
Zentek Ltd. ZTEK
5 fiscal years on record · CAD · FY2024 reported
SEC FILINGS ONLY
Revenue · FY2024
CAD 872,495
▲ 2826.3% vs FY2023
EPS · FY24
CAD -0.10
Dividend / sh · FY24
—
Payout · FY24
—
ROE · FY24
—
Net margin · FY24
-1150.7%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
CAD 872,495.00
Revenue, FY2024 · full 5-year series below
Revenue
Net income
The company lost 1151 cents on every revenue dollar this year.
Per share
CAD -0.10
Diluted EPS, FY2024
EPS
The company pays no cash dividend.
Profitability
—
Return on equity, FY2024
ROE
Operating margin-1100.9%
Net margin-1150.7%
Return on assets-49.0%
Returned to shareholders
—
returned in FY2024 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
—
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+36.0%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
—
Shares outstanding, FY2024
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
CAD 18.4M
total assets, end of FY2024
Total assetsCAD 18.4M
CashCAD 121,481.00
Current ratio1.25×
History
5 fiscal years
Every figure from documents filed with the SEC · CAD
Metric
2024
2023
2022
2021
2020
Revenue CAD B
0.0
0.0
0.0
0.0
0.0
Operating income CAD B
−0.0
−0.0
−0.0
−0.0
−0.0
EBITDA CAD B
−0.0
−0.0
−0.0
·
·
Income tax CAD B
0.0
0.0
0.0
0.0
0.0
Net income CAD B
−0.0
−0.0
−0.0
−0.0
−0.0
EPS, diluted CAD
−0.10
−0.12
−0.14
−0.34
0.05
Dividend / sh CAD
·
·
·
·
·
Payout %
·
·
·
·
·
ROE %
·
·
·
·
·
Shares out B
·
·
·
·
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
16 of 16
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed